| RISPERIDONE | ||
|
PRODUCT IDENTIFICATION |
||
| CAS NO. | 106266-06-2 |
|
| EINECS NO. | ||
| FORMULA | C23H27FN4O2 | |
| MOL WT. | 410.49 | |
|
H.S. CODE |
||
|
TOXICITY |
||
| SYNONYMS | Risperidal; | |
| 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl)ethyl)-6,7,8,9-tetrahydro-2- methyl-4H-pyrido [1,2-a] pyrimidin-4-one. | ||
| DERIVATION |
|
|
|
CLASSIFICATION |
||
|
PHYSICAL AND CHEMICAL PROPERTIES |
||
| PHYSICAL STATE | White powder | |
| MELTING POINT | ||
| BOILING POINT | ||
| SPECIFIC GRAVITY | ||
| SOLUBILITY IN WATER | Insoluble | |
| pH | ||
| VAPOR DENSITY |
| |
|
AUTOIGNITION |
| |
|
NFPA RATINGS |
||
|
REFRACTIVE INDEX |
||
| FLASH POINT |
| |
| STABILITY | Stable under ordinary conditions. | |
|
APPLICATIONS |
||
| Antihistamine is a group of drugs characterized by the ability to block the action of histamines on H1 receptors. The principal use is to treat allergies, hives, and other local and systemic hypersensitivity reactions. Some antihistamines can also be used in the control of insomnia, motion sickness, or vertigo. First-generation antihistamines can cause side effect of sedation. Second-generation antihistamines (fexofenadine, loratadine) are nonsedating. Risperidone, a benzisoxazole derivative compound, is used as an antipsychotic agent for the therapy in schizophrenia and other related psychotic disorders. It is a white to off-white powder; insoluble in water, soluble in methylene chloride, methanol and dilute acid. Its chemical designation is 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl)ethyl)-6,7,8,9-tetrahydro-2- methyl-4H-pyrido [1,2-a] pyrimidin-4-one. | ||
| SALES SPECIFICATION | ||
|
APPEARANCE |
White to off-white powder | |
|
IDENTIFICATION |
Complies ( IR spectrum) |
|
|
ASSAY (HPLC) |
98.5 - 101.0% | |
| SOLUTION CLARITY | clear and colorless | |
|
LOSS ON DRYING |
0.5% max |
|
| HEAVY METALS |
20ppm max |
|
|
SOLVENT RESIDUE |
0.5% max |
|
| SULFATED ASH | 0.1% max | |
| TRANSPORTATION | ||
| PACKING | 25kgs in fiber drum | |
| HAZARD CLASS | ||
| UN NO. | ||
GENERAL DESCRIPTION OF ANTIPSYCHOTIC AGENTS |
||
The term antipsychotic refers to a group of drugs effective in the treatment of
psychosis including schizophrenic, paranoid, schizoaffective, bipolar disorder,
and other psychotic disorders. Traditional antipsychotic agents have
phenothiazine structure chemically. Phenothiazinene drugs are adrenergic
blocking agents. Their pharmacologic actions including central nervous system
depression, prolongation and potentiation of the effects of narcotic and
hypnotic drugs, hypotensive activity, and antispasmodic, antihistaminic, and
antiemetic activity. Other chemcial structures for antipsychotic drugs are
diverse, they include thioxanthene, butyrophenone, dibenzoxazepine,
dihydroindolone, benzisoxazole, and diphenylbutylpiperidine. Antipsychotic
agents bind to dopamine, histamine, muscarinic cholinergic, a-adrenergic, and
serotonin receptors. Blockade of dopaminergic transmission in various areas is known
to be responsible for their major effects such as not
only antipsychotic action by
blockade in the mesolimbic and mesocortical areas and and antiemetic effects by blockade in the chemoreceptor trigger
zone of the medulla but also extrapyramidal side effects
(dystonia, akathisia, parkinsonism, and tardive dyskinesia) by blockade in the
basal ganglia and sedation and autonomic side effects (orthostatic
hypotension, blurred vision, dry mouth, nasal congestion, and constipation) by blockade of histamine, cholinergic, and adrenergic receptors.
The antipsychotic agents may be divided by chemical group and and the decreased propensity of extrapyramidal side effects
into two main groups and a new class which is being
processed.
|
||